E-LIB Suche - Ergebnisse für: Hess, Dagmar

1

TLD-1, a novel liposomal doxorubicin, in patients with adva..:

Colombo, Ilaria ; Koster, Kira-Lee ; Holer, Lisa...
European Journal of Cancer. 201 (2024) - p. 113588 , 2024

Link: https://doi.org/10.1016/..

2

Population pharmacokinetics of TLD-1, a novel liposomal dox..:

Mc Laughlin, Anna M. ; Hess, Dagmar ; Michelet, Robin...
Cancer Chemotherapy and Pharmacology. , 2024

Link: https://doi.org/10.1007/..

3

Phase 1 first-in-human dose-escalation study of ANV419 in p..:

Joerger, Markus ; Calvo, Emiliano ; Laubli, Heinz...
Journal for ImmunoTherapy of Cancer. 11 (2023) 11 - p. e007784 , 2023

Link: https://doi.org/10.1136/..

4

P625: A PHASE 1B/2 STUDY OF NAVTEMADLIN COMBINED WITH ACALA..:

Byrd, John C. ; Ali Bhat, Seema ; Awan, Farrukh...
HemaSphere. 7 (2023) S3 - p. e197904a , 2023

Link: https://doi.org/10.1097/..

5

A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patie..:

Hanna, Glenn J. ; Stathis, Anastasios ; Lopez-Miranda, Elena...
Cancer Research Communications. 3 (2023) 9 - p. 1853-1861 , 2023

Link: https://doi.org/10.1158/..

6

SAKK 35/15: a phase 1 trial of obinutuzumab in combination ..:

Stathis, Anastasios ; Mey, Ulrich ; Schär, Sämi...
Blood Advances. 6 (2022) 13 - p. 3911-3920 , 2022

Link: https://doi.org/10.1182/..

7

Einfach Liebe:

Hess, Dagmar ; Hess, Silke ; Langhirt, Sabine
Spektrum der Mediation; Back to normal – Beziehungen neu gestalten. 19 (2022) 1 - p. 32-35 , 2022

Link: https://doi.org/10.30820..

8

Phase 1 Dose Escalation Study of the Allosteric AKT Inhibit..:

Schneeweiss, Andreas ; Hess, Dagmar ; Joerger, Markus...
Cancers. 11 (2019) 12 - p. 1987 , 2019

Link: https://doi.org/10.3390/..

9

A Phase 1 study of BAL101553, a novel tumor checkpoint cont..:

Joerger, Markus ; Stathis, Anastasios ; Metaxas, Yannis...
Investigational New Drugs. 38 (2019) 4 - p. 1067-1076 , 2019

Link: https://doi.org/10.1007/..

10

First-in human, phase 1, dose-escalation pharmacokinetic an..:

Wicki, Andreas ; Brown, Nicholas ; Xyrafas, Alexandros...
European Journal of Cancer. 96 (2018) - p. 6-16 , 2018

Link: https://doi.org/10.1016/..

11

A phase I, open-label, multicenter study to evaluate the ph..:

Slingerland, Marije ; Hess, Dagmar ; Clive, Sally...
Cancer Chemotherapy and Pharmacology. 74 (2014) 5 - p. 1089-1098 , 2014

Link: https://doi.org/10.1007/..

12

Immunologic response to the survivin-derived multi-epitope ..:

Lennerz, Volker ; Gross, Stefanie ; Gallerani, Elisa...
Cancer Immunology, Immunotherapy. 63 (2014) 4 - p. 381-394 , 2014

Link: https://doi.org/10.1007/..

13

A phase I, open-label, multicenter study to evaluate the ph..:

Sharma, Sunil ; Witteveen, Petronella O. ; Lolkema, Martijn P....
Cancer Chemotherapy and Pharmacology. 75 (2014) 1 - p. 87-95 , 2014

Link: https://doi.org/10.1007/..

14

Improvement in hereditary hemorrhagic telangiectasia after ..:

Geisthoff, Urban W. ; Nguyen, Ha-Long P. ; Hess, Dagmar
Annals of Hematology. 93 (2013) 4 - p. 703-704 , 2013

Link: https://doi.org/10.1007/..

15

A phase I dose-escalation study of MSC1992371A, an oral inh..:

Graux, Carlos ; Sonet, Anne ; Maertens, Johan...
Leukemia Research. 37 (2013) 9 - p. 1100-1106 , 2013

Link: https://doi.org/10.1016/..